Condition
Breast Cancer - Infiltrating Ductal Carcinoma
Total Trials
3
Recruiting
3
Active
3
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Recruiting3
Clinical Trials (3)
Showing 3 of 3 trials
NCT07506876Phase 2RecruitingPrimary
Concurrent Neoadjuvant Chemo/Endocrine Therapy in HER2+ Breast Cancer
NCT07206121Not ApplicableRecruiting
Feasibility Study for the SIRA-1000, SIRA® RFA Electrosurgical Device as an Adjunct to Breast Conserving Surgery
NCT07331506Recruiting
Validation of the Oncoliq Test for the Early Detection of Breast Cancer.
Showing all 3 trials